The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes
Abstract
Objective: We developed a novel non-insulin-based fasting score to evaluate insulin sensitivity validated against the euglycemic–hyperinsulinemic clamp (EHC). We also evaluated its correlation with ectopic fact accumulation and its capacity to predict incident type 2 diabetes mellitus (T2D). Design and methods: The discovery sample was composed by 125 subjects (57 without and 68 with T2D) that underwent an EHC. We defined METS-IR as Ln((2*G 0)+TG 0)*BMI)/(Ln(HDL-c)) (G 0: fasting glucose, TG 0: fasting triglycerides, BMI: body mass index, HDL-c: high-density lipoprotein cholesterol), and compared its diagnostic performance against the M-value adjusted by fat-free mass (MFFM) obtained by an EHC. METS-IR was validated in a sample with EHC data, a sample with modified frequently sampled intravenous glucose tolerance test (FSIVGTT) data and a large cohort against HOMA-IR. We evaluated the correlation of the score with intrahepatic and intrapancreatic fat measured using magnetic resonance spectroscopy. Subsequently, we evaluated its ability to predict incident T2D cases in a prospective validation cohort of 6144 subjects. Results: METS-IR demonstrated the better correlation with the MFFM (ρ = −0.622,P < 0.001) and diagnostic performance to detect impaired insulin sensitivity compared to both EHC (AUC: 0.84, 95% CI: 0.78–0.90) and the SI index obtained from the FSIVGTT (AUC: 0.67, 95% CI: 0.53–0.81). METS-IR significantly correlated with intravisceral, intrahepatic and intrapancreatic fat and fasting insulin levels (P < 0.001). After a two-year follow-up, subjects with METS-IR in the highest quartile (>50.39) had the highest adjusted risk to develop T2D (HR: 3.91, 95% CI: 2.25–6.81). Furthermore, subjects with incident T2D had higher baseline METS-IR compared to healthy controls (50.2 ± 10.2 vs 44.7 ± 9.2,P < 0.001). Conclusion: METS-IR is a novel score to evaluate cardiometabolic risk in healthy and at-risk subjects and a promising tool for screening of insulin sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Simental-Mendía, L. E., Rodríguez-Morán, M., & Guerrero-Romero, F. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0034 · Cited by 2,445
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Shulman, G. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1011035 · Cited by 1,126
Er, L.-K., Wu, S., Chou, H.-H., Hsu, L.-A., Teng, M.-S., Sun, Y.-C., & Ko, Y.-L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149731 · Cited by 708
Wong, V. W.-S., Chu, W. C.-W., Wong, G. L.-H., Chan, R. S.-M., Chim, A. M.-L., Ong, A., Yeung, D. K.-W., Yiu, K. K.-L., Chu, S. H.-T., Woo, J., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300342 · Cited by 491
Lomonaco, R., Ortiz-Lopez, C., Orsak, B., Webb, A., Hardies, J., Darland, C., Finch, J., Gastaldelli, A., Harrison, S., Tio, F., et al. (2012) · Hepatology · doi:10.1002/hep.25539 · Cited by 459
Gastaldelli, A., Gaggini, M., & DeFronzo, R. A. (2017) · Diabetes · doi:10.2337/db16-1167 · Cited by 344
Wong, V. W.-S., Wong, G. L.-H., Yeung, D. K.-W., Abrigo, J. M., Kong, A. P.-S., Chan, R. S.-M., Chim, A. M.-L., Shen, J., Ho, C.-S., Woo, J., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.1 · Cited by 275
Lee, S.-H., Kwon, H.-S., Park, Y.-M., Ha, H.-S., Jeong, S. H., Yang, H. K., Lee, J.-H., Yim, H.-W., Kang, M.-I., Lee, W.-C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090430 · Cited by 275
Selection of the appropriate method for the assessment of insulin resistance
Borai, A., Livingstone, C., Kaddam, I., & Ferns, G. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-158 · Cited by 268
Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome
Roberts, L. D., Koulman, A., & Griffin, J. L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70143-8 · Cited by 263
Wang, F., Han, L., & Hu, D. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.009 · Cited by 247
Abbasi, F., & Reaven, G. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.006 · Cited by 240
Vega, G. L., Barlow, C. E., Grundy, S. M., Leonard, D., & DeFina, L. F. (2014) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000044 · Cited by 235
Insulin resistance and coronary heart disease in nondiabetic individuals
Reaven, G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241885 · Cited by 227
Campbell, P. J., Mandarino, L. J., & Gerich, J. E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90023-6 · Cited by 226
The biochemical assessment of insulin resistance
Borai, A., Livingstone, C., & Ferns, G. A. A. (2007) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456307780945778 · Cited by 184
Otten, J., Ahrén, B., & Olsson, T. (2014) · Diabetologia · doi:10.1007/s00125-014-3285-x · Cited by 170
Kannel, W. B., Vasan, R. S., Keyes, M. J., Sullivan, L. M., & Robins, S. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.09.109 · Cited by 164
Impact of Degree of Obesity on Surrogate Estimates of Insulin Resistance
Kim, S. H., Abbasi, F., & Reaven, G. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1998 · Cited by 150
Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup
Marcovina, S., Bowsher, R. R., Miller, W. G., Staten, M., Myers, G., Caudill, S. P., Campbell, S. E., Steffes, M. W., & Workgroup, F. T. I. S. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.082214 · Cited by 136
Roles of insulin resistance and obesity in regulation of plasma insulin concentrations
Jones, C. N. O., Abbasi, F., Carantoni, M., Polonsky, K. S., & Reaven, G. M. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.3.e501 · Cited by 134
Epidemiology of diabetes mellitus in Mexico
Bello‐Chavolla, O. Y., Rojas, R., Aguilar-Salinas, C. A., & Hernández‐Ávila, M. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nuw030 · Cited by 123
Self-citationLee, C. H., Shih, A. Z. L., Woo, Y. C., Fong, C. H. Y., Leung, O. Y., Janus, E., Cheung, B. M. Y., & Lam, K. S. L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163424 · Cited by 114
Ectopic fat accumulation in the pancreas and its biomarkers: A systematic review and meta‐analysis
Singh, R. G., Yoon, H. D., Poppitt, S., Plank, L. D., & Petrov, M. S. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2918 · Cited by 110
Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance
Wueest, S., Item, F., Lucchini, F. C., Challa, T. D., Müller, W., Blüher, M., & Konrad, D. (2015) · Diabetes · doi:10.2337/db15-0941 · Cited by 105
Lee, S., Han, K., Yang, H. K., Kim, M. K., Yoon, K., Kwon, H., & Park, Y. (2014) · Clinical Endocrinology · doi:10.1111/cen.12502 · Cited by 91
Bastard, J., Vandernotte, J.-M., Faraj, M., Karelis, A. D., Messier, L., Malita, F. M., Garrel, D. R., Prud’homme, D., & RABASA-LHORET, R. P. R. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.02.004 · Cited by 78
The euglycemic hyperinsulinemic clamp examination: variability and reproducibility
L. Bokemark, A. F. (2000) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510050185010 · Cited by 61
Coates, P., Luzio, S., Brunel, P., & Owens, D. (1995) · Diabetes · doi:10.2337/diab.44.6.631 · Cited by 59
Kato, K., Takamura, T., Takeshita, Y., Ryu, Y., Misu, H., Ota, T., Tokuyama, K., Nagasaka, S., Matsuhisa, M., Matsui, O., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092170 · Cited by 49
Vanhala, P., Vanhala, M. J., Kumpusalo, E., & Keinanen-Kiukaanniemi, S. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020591 · Cited by 48
Mehta, S. R., Godsland, I. F., Thomas, E. L., Pavitt, D. V., Morin, S. H., Bell, J. D., Taylor-Robinson, S. D., & Johnston, D. G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2430 · Cited by 33
Man, C. D., Piccinini, F., Basu, R., Basu, A., Rizza, R. A., & Cobelli, C. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00482.2012 · Cited by 26
PREVALENCE OF METABOLIC SYNDROME IN YOUNG MEXICANS: A SENSITIVITY ANALYSIS ON ITS COMPONENTS.
Murguía‐Romero, M., Jiménez-Flores, J. R., Sigrist-Flores, S. C., et al. (2015) · PubMed · doi:10.3305/nh.2015.32.1.9031 · Cited by 17
The Role of Diet in Patients with Metabolic Syndrome
Almeda‐Valdés, P., Herrera-Mercadillo, R. J., Aguilar-Salinas, C. A., Uribe, M., & Méndez‐Sánchez, N. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170518095316 · Cited by 17
Self-citation
Cited by
Duan, M., Zhao, X., Li, S., Miao, G., Bai, L., Zhang, Q., Yang, W., & Zhao, X. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02334-8 · Cited by 236
Xie, Q., Kuang, M., Lu, S., Huang, X., Wang, C., Zhang, S., Sheng, G., & Zou, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1175988 · Cited by 24
“The hyperinsulinemic-euglycemic clamp is recognized as the gold standard for evaluating IR, but due to the relatively complicated measurement method, it cannot be widely used in large-scale epidemiological investigations; While MetS-IR, as a simple IR surrogate indicator, is considered to be widely used (16).”
BackgroundMethodInfluentialUysal, E., Tammo, O., Soylemez, E., Incebıyık, M., Filiz, D., & Alci, M. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01701-6 · Cited by 23
Metadata
- Authors
- Bello-Chavolla, O. Y., Almeda-Valdes, P., Gomez-Velasco, D., Viveros-Ruiz, T., Cruz-Bautista, I., Romo-Romo, A., Sánchez-Lázaro, D., Meza-Oviedo, D., Vargas-Vázquez, A., Campos, O. A., Sevilla-González, M. D. R., Martagón, A. J., Hernández, L. M., Mehta, R., Caballeros-Barragán, C. R., & Aguilar-Salinas, C. A.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-05
- Volume
- 178
- Issue
- 5
- Pages
- 533-544
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2793064977
- Cited by
- 664
- References
- 40
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.